Frazier Healthcare Partners Adds Highly Experienced Investor to Life Sciences Team
Frazier Healthcare Partners announced the planned addition of Albert Cha, M.D., Ph.D. as Managing Partner on the Life Sciences team. He has over 20 years of experience investing in public and private biopharmaceutical...
VYNE Therapeutics (formerly Menlo Therapeutics) to Present at the Cantor Fitzgerald and H.C. Wainwright Investment Conferences in September
BRIDGEWATER, N.J., Sept. 09, 2020 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that David Domzalski, Chief Executive Officer, will present...
Menlo Therapeutics Announces Completion of Corporate Name Change to VYNE Therapeutics
Will commence trading under new Nasdaq Ticker “VYNE”, September 8, 2020
Menlo Therapeutics Announces Corporate Name Change to VYNE Therapeutics
Company will commence trading under new ticker “VYNE” on September 8, 2020